PEG-MGF
Overview
PEG-MGF is a pegylated derivative of Mechano Growth Factor designed to extend systemic half-life through the addition of polyethylene glycol moieties. Pegylation reduces renal clearance and proteolytic degradation, theoretically allowing for less frequent dosing and broader tissue distribution compared to unmodified MGF.
Mechanism of Action
The modified peptide retains the proposed satellite cell activation properties of native MGF..
Research Summary & Key Findings
No published clinical or preclinical studies have characterized the pharmacology, safety, or efficacy of PEG-MGF in any species. Available information is derived from unverified commercial sources and anecdotal reports. This compound has not been subjected to regulatory review and remains wholly investigational.
Clinical Status
PEG-MGF is in the research phase with limited clinical data in humans. Current evidence is primarily derived from preclinical (animal or in vitro) studies.
Administration Routes
Related Peptides in Performance
Melanotan II
Research PhaseA synthetic cyclic analog of alpha-melanocyte stimulating hormone (alpha-MSH) that non-selectively activates melanocorti...
View detailsIGF-1 LR3 (Long-Arg3)
Research PhaseIGF-1 LR3 is a synthetic analogue of insulin-like growth factor 1 with an N-terminal extension of 13 amino acids and a s...
View detailsIGF-1 DES (1-3)
Research PhaseIGF-1 DES (1-3) is a truncated analogue of insulin-like growth factor 1 lacking the first three N-terminal amino acids (...
View detailsMGF (Mechano Growth Factor)
Research PhaseMechano Growth Factor is a splice variant of the IGF-1 gene expressed in response to mechanical stress on muscle tissue....
View detailsFind a Pharmacy
Browse PCAB-accredited and FDA 503B-registered compounding pharmacies that supply PEG-MGF.
Pharmacy DirectoryJoin the Association
Access exclusive peptide protocols, provider resources, and community support.
List Your PracticeDisclaimer: This information is provided for educational and research purposes only. It is not intended as medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before starting any peptide therapy. The Peptide Association does not endorse or recommend any specific treatment protocol.